NEW YORK, Dec. 14, 2016 -- Dr. Carlos Encarnacion, Physician at Texas Oncology, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in Medical Oncology and Hematology and Cancer Genetics.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1935bcff-f4bf-472b-8836-d6c7ca54f754
Dr. Encarnacion has been active in the healthcare industry for the past 23 years and specifically 20 years at Texas Oncology. He obtained his MD from the University of Puerto Rico School of Medicine in 1986 and completed his Fellowship in Oncology from the University of Texas Health Science Center at San Antonio in 1993.
Texas Oncology, a statewide physician-led practice, conducts innovative research and delivers leading-edge technology and treatment options. Founders of the practice pioneered community-based care to enable more cancer patients to receive high-quality care while staying close to the critical support of family and friends.
Dr. Encarnacion’s day-to-day responsibilities include treating all forms of cancer, with a specialty in breast cancer. He is the area Medical Director, oversees the local Clinical Genetic Program, and serves as Site Research Leader. He also chairs the Cancer Committee at Providence Health Center.
Dr. Encarnacion attributes his success to his interaction with his patients and enjoys working with an excellent crew of dedicated professionals. His long-term goals include improving cancer awareness in the local community and continued upward movement through the research program within his network.
Dr. Encarnacion’s many awards and honors include: Dean’s List, University of Puerto Rico; Alpha-Omega-Alpha Honor Medical Society; Certificate of Merit, University of Puerto Rico School of Medicine; Scientific Research Award, ACP Puerto Rico Chapter; American Cancer Society Fellowship; Ciba-Geigy Fellowship Grant, Katherine Wood Johnson Travel Award; Upjohn Travel Award; Fellow, American College of Physicians; and Friend of the ACS Award. He has been a speaker for the American Cancer Society, Providence Cancer Program, and Texas Oncology in multiple venues.
Dr. Encarnacion is affiliated with the American College of Physicians, Texas Medical Association, McLennan County Medical Society, and American Society of Clinical Oncology, as well as the non-profit organization Commemorative Air Force (CAF).
In his free time, Dr. Encarnacion enjoys working out, beekeeping, and flying.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



